Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors

A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.

Hims & Hers Powers YieldMax's Latest Options-Based Income ETF

Chandrima Sanyal
September 26, 2025

YieldMax ETFs grew its expanding lineup of income-oriented funds on Tuesday with the introduction of the YieldMax HIMS Option Income Strategy ETF (NYSE: HIYY).

The new fund aims to provide current income by utilizing options-based strategies related to Hims & Hers Health Inc (NYSE: HIMS), a prominent consumer health and wellness business.

HIMS stock is showing exceptional strength. See if it is worth your attention here.

Unlike other equity ETFs, HIYY does not actually invest in Hims & Hers shares. Instead, the fund uses options strategies in an effort to provide advanced income streams for shareholders. Tidal Investments LLC will be the fund’s investment adviser, handling the daily strategy and risk exposure of HIYY.

Also Read: Amid Ethereum Swings, REX-Osprey Brings A Surprising Way To Invest In ETH

The introduction of HIYY represents the newest member of the YieldMax family of offerings, which is recognized for emphasizing income generation.

“With HIYY, investors have an opportunity to access options-based income potential tied to a wellness company with high-growth prospects without owning the underlying stock outright,” a representative for YieldMax said.

Investors in HIYY will be able to count on the fund being categorised as a Group D ETF for distribution purposes. Its initial distribution is expected to be announced on Oct. 22, providing a timing for income-focused investors to project their cash flows.

YieldMax ETFs have increasingly become popular in the market for their customized solutions that focus on generating immediate income, making them attractive to retail and institutional investors. The company’s strategy, which typically incorporates strategic options overlays alongside equity exposure, is intended to provide steady income potential under changing market conditions.

Industry observers point out that options-based ETFs such as HIYY present investors with an alternative to traditional dividends, particularly in industries such as health and wellness, where constituent stocks might not pay frequent dividends.

By concentrating on HIMS, a rapidly growing business in telehealth and customized care, HIYY gives investors access to a popular health care niche while avoiding direct equity risk.

Read next:

  • From AI To Delivery Drones: Defiance’s JEDI ETF Targets Next-Gen Autonomy

Photo: Courtesy Lori Butcher via Shutterstock.

Continue Reading...

Popular

Donald Trump's Approval Rating Crashes to Record Low — Here's What's Driving the Decline

According to the recent YouGov/Economist poll, President Trump's approval rating has taken a nosedive, reaching its lowest point in his second term.

Bitcoin Struggles Around $112,000, But Here's Why The Bull Run Is Not Over Yet

Bitcoin's (CRYPTO: BTC) is languishing around $112,000, but a prominent trader remains adamant about a strong end to the year.

Why This Crypto Skeptic Had a Change of Heart - Ad

He used to make fun of crypto. Now... he says one $3 crypto could rise to $92 by next year.

America Has A New No. 1 Beer — And It's Got Bud Light DNA

When it comes to beer in the United States, there's a new bestselling brand.

Elon's $25 Trillion Confession - Ad

Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.

Cathie Wood Loads Up On Bullish Inc, Pony AI And Robinhood — Dumps Kratos Defense Amid Taiwan Drone Buzz

On Sept 17, 2025, Cathie Wood-led Ark Invest executed significant trades involving Bullish, Kratos Defense, Pony AI, and Robinhood. These reflect Ark's focus on emerging tech and defense sectors.

New Biotech Offering Targets $426B Rare Disease Market - Ad

The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.

Hillary Clinton Says Trump Administration Is 'Going Great' For The President, Dogecoin Rallies 20%, Silver Token Tops Bitcoin — This Week In Crypto

The past week has been a rollercoaster ride in the world of finance and politics. From silver-backed cryptocurrencies outperforming Bitcoin (CRYPTO: BTC) to Hillary Clinton’s accusations of crypto corruption against the Trump administration, there’s been no shortage of headlines.

Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad

This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.

US jobless aid applications retreat to 231,000 after surging to nearly 4-year high a week earlier

The number of Americans applying for jobless aid last week retreated significantly after surging to a nearly four-year high a week earlier.

Spain sweltered under hottest summer on record

MADRID (AP) — Spain said Tuesday that this summer was the hottest on record for the southern European nation, which like the entire Mediterranean region is being hard hit by climate change.

The "Mar-A-Lago Accord" Is Now Underway - Ad

The global order is in chaos. And according to 40-year market veteran Dr. David Eifrig, the biggest controlled demolition of the old monetary order in history could now be here, too. That means if you don't take action today, your wealth could decline by 40%... (Yes, even your cash savings.)

Trump Warns Russia As Fighter Jets Breach NATO Airspace: 'I Don't Love It…Could Be Big Trouble'

U.S. President Donald Trump warned that Russia's fighter jet incursion into Estonia's airspace "could be big trouble," as NATO scrambled jets, Estonia requested Article 4 consultations, and Trump tied his Russia sanctions strategy to unified NATO action and tariffs on China.

Trump Admin Pushes G7, EU To Slap Tariffs On China And India Over Russian Oil Purchase To 'End The Senseless Killing' In Ukraine

The U.S. is pressing G7 and EU allies to impose tariffs on China and India for buying Russian oil, while Trump's trade war policies have driven tariff revenues to a record $30 billion in August.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

Block CEO Jack Dorsey Invites Businesses Using Square PoS System To Test Bitcoin Payments Feature

Jack Dorsey, co-founder and CEO of Block Inc. (NYSE:XYZ), on Monday encouraged merchants using the company's Square platform to test Bitcoin (CRYPTO: BTC) payments.

Trump's Immigration Policies Could 'Shrink' GDP Growth As US Population Projected To Decline, Warns CBO

The U.S. population growth is expected to decline at a faster rate than previously projected due to President Donald Trump's immigration policies, according to the Congressional Budget Office (CBO).

Time to Say Goodbye to "Old" Dollar? Say Hello to "Trump's New Dollar" - Ad

If you have any money in U.S. dollars... learn how to prepare for "Trump's new dollar"... Because this could be the biggest change to our financial system in 54 years. President Trump even called it: "The greatest revolution in financial technology since the birth of the internet itself."

How the Multiplier Effect is Working on This $3 Crypto - Ad

It's called the multiplier effect in crypto. In short, because of a lack of supply, small inflows of cash can create major moves in the overall value of the crypto. And it's particularly strong in one $3 crypto. Crypto analysts are suggesting it could rise to as high as $100 by next year.

Lam Research And JSR Resolve Legal Disputes As They Team Up On AI Era Chips

Lam Research and JSR Corp agreed to collaborate and cross-license, combining their expertise to accelerate semiconductor manufacturing and reduce costs.

Big Tech's energy-hungry data centers could be bumped off grids during power emergencies

HARRISBURG, Pa. (AP) — With the explosive growth of Big Tech's data centers threatening to overload U.S. electricity grids, policymakers are taking a hard look at a tough-love solution: bumping the energy-hungry data centers off grids during power emergencies.

Want To Know the No.1 Crypto and the No.1 Stock? - Ad

The #1 crypto is just $3. Crypto analysts say a cash injection could drive it as high as $100 in the next year. The #1 stock is equally exciting. It's less than $10 but made a HUGE deal recently to work with Nvidia.

Apple's iPhone 17 Series Takes Off, Meta's New Smart Glasses And Major Partnerships In AI Space: This Week In AI

This weekend's tech roundup featured Apple's strong iPhone 17 launch in China and India, Meta's new smart glasses, major AI partnerships like Intel-Nvidia and PayPal-Google, and Jim Cramer questioning Huawei's chip breakthrough.

Web of business interests shows that Kimmel's future rests on far more than his jokes

NEW YORK (AP) — The decision about whether to keep on his late-night ABC show depends on far more than his jokes. The choice is complicated by a web of business and regulatory considerations involving ABC’s parent company, other media companies and the Trump administration.

Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors - Ad

A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.

From Wall Street To Web3: Carbon Markets Move On-chain

Tokenization could boost transparency, reduce fraud, and increase liquidity in carbon markets.

Why This Crypto Skeptic Had a Change of Heart - Ad

He used to make fun of crypto. Now... he says one $3 crypto could rise to $92 by next year.

Elon's $25 Trillion Confession - Ad

Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.

Family says a man who died after going on a Universal roller coaster never let wheelchair stop him

ORLANDO, Fla. (AP) — A 32-year-old man who from blunt impact injuries after going on a roller coaster at Universal Orlando Resort’s newest park used a wheelchair. But his family said it never stopped his unwavering spirit.

Day of strikes in France challenges new prime minister's budget plans

PARIS (AP) — Strikes and street demonstrations called by all major trade unions to denounce budget cuts were expected Thursday across France, as new talks with political opponents about curbing .

New Biotech Offering Targets $426B Rare Disease Market - Ad

The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.

US sanctions Iranian financiers, others over $100M in cryptocurrency transfers from Iran oil sales

WASHINGTON (AP) — A pair of Iranian financiers and more than a dozen people and firms across Hong Kong and the United Arab Emirates were sanctioned Tuesday for allegedly coordinating $100 million worth of cryptocurrency transfers from the sale of Iranian oil for the benefit of Iran's government and military.

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright priceactionea.net
Privacy Policy | Terms of Service